Horizon Kinetics’s Avanos Medical AVNS Stock Holding History

Horizon Kinetics’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$478K	Buy	10,658 +9	+0.1%	+$472	0.02%	246
2018 Q3	$729K	Sell	10,649 -4	-0%	-$257	0.02%	224
2018 Q2	$610K	Sell	10,653 -8	-0.1%	-$423	0.02%	242
2018 Q1	$491K	Buy	10,661 +5	+0%	+$237	0.01%	273
2017 Q4	$493K	Sell	10,656 -8,000	-43%	-$368K	0.01%	268
2017 Q3	$840K	Sell	18,656 -1,002	-5%	-$42.8K	0.02%	209
2017 Q2	$772K	Hold	19,658	–	–	0.03%	225
2017 Q1	$749K	Hold	19,658	–	–	0.02%	230
2016 Q4	$727K	Sell	19,658 -35	-0.2%	-$1.25K	0.02%	230
2016 Q3	$683K	Buy	19,693 +2	+0%	+$70	0.02%	250
2016 Q2	$640K	Sell	19,691 -10,540	-35%	-$323K	0.02%	266
2016 Q1	$869K	Sell	30,231 -5,990	-17%	-$160K	0.02%	217
2015 Q4	$1.21M	Sell	36,221 -9	-0%	-$280	0.03%	170
2015 Q3	$1.03M	Hold	36,230	–	–	0.02%	187
2015 Q2	$1.47M	Sell	36,230 -52	-0.1%	-$2.33K	0.02%	180
2015 Q1	$1.78M	Buy	+36,282	New	+$1.68M	0.02%	170

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Horizon Kinetics's AVNS Position: Q4 2018 in Review

Horizon Kinetics increased its Avanos Medical (AVNS) stake by 0.08% in Q4 2018, buying an estimated $472 and bringing the position to 10,658 shares worth $478K. The position accounts for 0.02% of the portfolio, ranked #246.

Horizon Kinetics first reported a position in AVNS in Q1 2015 and has held it in 16 quarters since. The position peaked at $1.78M in Q1 2015. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

Horizon Kinetics held 10,658 shares of Avanos Medical worth $478K as of Q4 2018.
Horizon Kinetics bought 9 Avanos Medical shares in Q4 2018, an estimated $472.
Avanos Medical made up 0.02% of Horizon Kinetics's portfolio in Q4 2018, its #246 holding.
Horizon Kinetics first reported a position in Avanos Medical in Q1 2015 and has held it in 16 quarters since.
Horizon Kinetics's Avanos Medical position peaked at $1.78M in Q1 2015.
350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on Horizon Kinetics's 13F filing for Q4 2018, filed 14 Feb 2019.